Prime Medicine
PRME
PRME
83 hedge funds and large institutions have $472M invested in Prime Medicine in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+4
Holders Change %
+5.06%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
35
Reduced
15
Closed
6
Calls
$97K
Puts
$10K
Net Calls
+$87K
Net Calls Change
+$87K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$16.1M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$37.7M |
| 3 |
3
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
$34.7M |
| 4 |
NAMA
4
Nikko Asset Management Americas
New York
|
$34.6M |
| 5 |
5
BlackRock
New York
|
$31.8M |
